An industry perspective on pain treatment in the UK.

Jan-Uwe Claas and Mark Suett speak to Henry Ireland, Senior Drug Evaluations Editor: Dr Jan-Uwe Claas, General Manager, Grϋnenthal UK Ltd, and Dr Mark Suett, Interim Medical Director, discuss Grϋnenthal's role in pain management, the current barriers to improving treatment in the UK and the supporting role the company plays in advancing this field. Grünenthal UK Ltd is a subsidiary of Grünenthal GmbH, based in Aachen, Germany.